{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:33:50Z","timestamp":1792175630322,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03333-6","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:51:58Z","timestamp":1769727118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Process Optimisation, Pharmaceutical Characterisation, and in vitro Activity of Mesalamine Nanocrystals in PMA-differentiated THP-1\u00a0cell Lines in the Late Inflammatory and Profibrotic Phase"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7056-2170","authenticated-orcid":false,"given":"Sonam","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1062-5860","authenticated-orcid":false,"given":"Sakshi","family":"Kunjir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-7750","authenticated-orcid":false,"given":"Sadhana","family":"Dhyagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-3483","authenticated-orcid":false,"given":"Abhishek","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2189-2234","authenticated-orcid":false,"given":"Subramanian","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-6115","authenticated-orcid":false,"given":"Rajkumar","family":"Malayandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"3333_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.dld.2021.03.002","volume":"53","author":"A Armuzzi","year":"2021","unstructured":"Armuzzi A, Liguori G. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: a narrative review. Dig Liver Dis. 2021;53:803\u20138. https:\/\/doi.org\/10.1016\/j.dld.2021.03.002.","journal-title":"Dig Liver Dis"},{"key":"3333_CR2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720\u20137. https:\/\/doi.org\/10.1038\/nrgastro.2015.150.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3333_CR3","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1007\/s10620-023-08122-w","volume":"68","author":"KA Dunleavy","year":"2023","unstructured":"Dunleavy KA, Raffals LE, Camilleri M. Intestinal barrier dysfunction in inflammatory bowel disease: underpinning pathogenesis and therapeutics. Dig Dis Sci. 2023;68:4306\u201320. https:\/\/doi.org\/10.1007\/s10620-023-08122-w.","journal-title":"Dig Dis Sci"},{"key":"3333_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcmgh.2021.03.002","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury B, Hardisty G, Gray RD, Ho G. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cell Mol Gastroenterol Hepatol. 2021;12:321\u201333. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.03.002.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3333_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/biomedicines13020305","volume":"13","author":"V Calvez","year":"2025","unstructured":"Calvez V, Puca P, Di Vincenzo F, Del Gaudio A, Bartocci B, Murgiano M, et al. Novel insights into the pathogenesis of inflammatory bowel diseases. Biomedicines. 2025;13:305. https:\/\/doi.org\/10.3390\/biomedicines13020305.","journal-title":"Biomedicines"},{"key":"3333_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5217\/ir.2018.16.1.26","volume":"16","author":"SH Lee","year":"2018","unstructured":"Lee SH, Kwon JE, Cho M-L. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16:26\u201342. https:\/\/doi.org\/10.5217\/ir.2018.16.1.26.","journal-title":"Intest Res"},{"key":"3333_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28135081","volume":"28","author":"J S\u0142oka","year":"2023","unstructured":"S\u0142oka J, Madej M, Strzalka-Mrozik B. Molecular mechanisms of the antitumor effects of mesalazine and its preventive potential in colorectal cancer. Molecules. 2023;28: 5081. https:\/\/doi.org\/10.3390\/molecules28135081.","journal-title":"Molecules"},{"key":"3333_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12325-015-0206-4","volume":"32","author":"A Abinusawa","year":"2015","unstructured":"Abinusawa A, Tenjarla S. Release of 5-aminosalicylic acid (5-ASA) from mesalamine formulations at various pH levels. Adv Ther. 2015;32:477\u201384. https:\/\/doi.org\/10.1007\/s12325-015-0206-4.","journal-title":"Adv Ther"},{"key":"3333_CR9","doi-asserted-by":"publisher","first-page":"125547","DOI":"10.1016\/j.ijpharm.2025.125547","volume":"675","author":"H Jadhav","year":"2025","unstructured":"Jadhav H, Camp AV, Tannergren C, Lemmens G, Brouwers J, Vanuytsel T, et al. Challenges in predicting colonic luminal and tissue concentrations of mesalamine and acetyl mesalamine using physiologically based biopharmaceutics modeling. Int J Pharm. 2025;675:125547. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125547.","journal-title":"Int J Pharm"},{"key":"3333_CR10","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/BF01297074","volume":"38","author":"J Fallingborg","year":"1993","unstructured":"Fallingborg J, Christensen LA, Jacobsen BA, Rasmussen SN. Very low intraluminal colonic pH in patients with active ulcerative colitis. Dig Dis Sci. 1993;38:1989\u201393. https:\/\/doi.org\/10.1007\/BF01297074.","journal-title":"Dig Dis Sci"},{"key":"3333_CR11","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/acs.molpharmaceut.7b00426","volume":"14","author":"B Hens","year":"2017","unstructured":"Hens B, Tsume Y, Bermejo M, Paixao P, Koenigsknecht MJ, Baker JR, et al. Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs. Mol Pharm. 2017;14:4281\u201394. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00426.","journal-title":"Mol Pharm"},{"key":"3333_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13346-013-0185-4","volume":"4","author":"R Malayandi","year":"2014","unstructured":"Malayandi R, Kondamudi PK, Ruby PK, Aggarwal D. Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease. Drug Deliv Transl Res. 2014;4:187\u2013202. https:\/\/doi.org\/10.1007\/s13346-013-0185-4.","journal-title":"Drug Deliv Transl Res"},{"key":"3333_CR13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s11095-025-03891-7","volume":"42","author":"S Kunjir","year":"2025","unstructured":"Kunjir S, Pathare P, Sharma S, Deoriya J, Natesan S, Malayandi R. Influence of milling parameters on crystal morphology, thermal behavior, and dissolution of mesalamine nanocrystals. Pharm Res. 2025;42:1409\u201327. https:\/\/doi.org\/10.1007\/s11095-025-03891-7.","journal-title":"Pharm Res"},{"key":"3333_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/jpp\/rgaa012","volume":"73","author":"N Fan","year":"2021","unstructured":"Fan N, Li J, Li J. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100. J Pharm Pharmacol. 2021;73:185\u201392. https:\/\/doi.org\/10.1093\/jpp\/rgaa012.","journal-title":"J Pharm Pharmacol"},{"key":"3333_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y. Nanosizing \u2014 oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631\u201344. https:\/\/doi.org\/10.1016\/j.addr.2007.05.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"3333_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0378-5173(95)00122-Y","volume":"125","author":"GG Liversidge","year":"1995","unstructured":"Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 1995;125:91\u20137. https:\/\/doi.org\/10.1016\/0378-5173(95)00122-Y.","journal-title":"Int J Pharm"},{"key":"3333_CR17","doi-asserted-by":"publisher","unstructured":"Bodn\u00e1r K. Preparation, stabilisation and isolation of drug nanoparticles for improved bioavailability [Internet]. University of Limerick; 2018 [cited 2025 Oct 27]. https:\/\/doi.org\/10.34961\/2647","DOI":"10.34961\/2647"},{"key":"3333_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122546","volume":"345","author":"MY Jeong","year":"2024","unstructured":"Jeong MY, Kim S, Kim HR, Jeon J, Won SS, Yang K-J, et al. Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection. Carbohydr Polym. 2024;345: 122546. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122546.","journal-title":"Carbohydr Polym"},{"key":"3333_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041499","volume":"26","author":"N Guembe-Michel","year":"2025","unstructured":"Guembe-Michel N, Nguewa P, Gonz\u00e1lez-Gaitano G. Soluplus\u00ae-based pharmaceutical formulations: recent advances in drug delivery and biomedical applications. Int J Mol Sci. 2025;26: 1499. https:\/\/doi.org\/10.3390\/ijms26041499.","journal-title":"Int J Mol Sci"},{"key":"3333_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/TCRM.S493371","volume":"21","author":"J Pan","year":"2025","unstructured":"Pan J, Li Z, Ye C, Zhang X, Yang Q, Zhang X, et al. Mesalazine-induced acute pancreatitis in inflammatory bowel disease patients: a systematic review. Ther Clin Risk Manag. 2025;21:113\u201323. https:\/\/doi.org\/10.2147\/TCRM.S493371.","journal-title":"Ther Clin Risk Manag"},{"key":"3333_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/mp8000793","volume":"5","author":"DT Friesen","year":"2008","unstructured":"Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JaS. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm. 2008;5:1003\u201319. https:\/\/doi.org\/10.1021\/mp8000793.","journal-title":"Mol Pharm"},{"key":"3333_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.115828","volume":"233","author":"S Sarabu","year":"2020","unstructured":"Sarabu S, Kallakunta VR, Bandari S, Batra A, Bi V, Durig T, et al. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: effect of drug physicochemical properties. Carbohydr Polym. 2020;233: 115828. https:\/\/doi.org\/10.1016\/j.carbpol.2020.115828.","journal-title":"Carbohydr Polym"},{"key":"3333_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.xphs.2024.08.023","volume":"114","author":"DD Shah","year":"2025","unstructured":"Shah DD, Taylor LS. Chemistry and ionization of HPMCAS influences the dissolution and solution-mediated crystallization of posaconazole amorphous solid dispersions. J Pharm Sci. 2025;114:223\u201333. https:\/\/doi.org\/10.1016\/j.xphs.2024.08.023.","journal-title":"J Pharm Sci"},{"key":"3333_CR24","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.2c00895","volume":"20","author":"HT Nguyen","year":"2023","unstructured":"Nguyen HT, Van Duong T, Taylor LS. Impact of gastric pH variations on the release of amorphous solid dispersion formulations containing a weakly basic drug and enteric polymers. Mol Pharm. 2023;20:1681\u201395. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00895.","journal-title":"Mol Pharm"},{"key":"3333_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijpharm.2010.12.027","volume":"406","author":"S Verma","year":"2011","unstructured":"Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406:145\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.12.027.","journal-title":"Int J Pharm"},{"key":"3333_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpharm.2014.10.025","volume":"477","author":"H Yang","year":"2014","unstructured":"Yang H, Teng F, Wang P, Tian B, Lin X, Hu X, et al. Investigation of a nanosuspension stabilized by Soluplus\u00ae to improve bioavailability. Int J Pharm. 2014;477:88\u201395. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.025.","journal-title":"Int J Pharm"},{"key":"3333_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s44164-022-00017-w","volume":"1","author":"A Joshi","year":"2022","unstructured":"Joshi A, Soni A, Acharya S. In vitro models and ex vivo systems used in inflammatory bowel disease. In Vitro Model. 2022;1:213\u201327. https:\/\/doi.org\/10.1007\/s44164-022-00017-w.","journal-title":"In Vitro Model"},{"key":"3333_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193601","volume":"13","author":"T Starr","year":"2018","unstructured":"Starr T, Bauler TJ, Malik-Kale P, Steele-Mortimer O. The phorbol 12-myristate-13-acetate differentiation protocol is critical to the interaction of THP-1 macrophages with Salmonella Typhimurium. PLoS ONE. 2018;13: e0193601. https:\/\/doi.org\/10.1371\/journal.pone.0193601.","journal-title":"PLoS ONE"},{"key":"3333_CR29","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.15419\/bmrat.v8i9.693","volume":"8","author":"N Prajitha","year":"2021","unstructured":"Prajitha N, Mohanan PV. Cellular and immunological response of THP-1 cells in response to lipopolysaccharides and lipoteichoic acid exposure. Biomed Res Ther. 2021;8:4562\u201382. https:\/\/doi.org\/10.15419\/bmrat.v8i9.693.","journal-title":"Biomed Res Ther"},{"key":"3333_CR30","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1002\/jsfa.4425","volume":"91","author":"C dos Santos","year":"2011","unstructured":"dos Santos C, Buera MP, Mazzobre MF. Phase solubility studies and stability of cholesterol\/\u03b2-cyclodextrin inclusion complexes. J Sci Food Agric. 2011;91:2551\u20137. https:\/\/doi.org\/10.1002\/jsfa.4425.","journal-title":"J Sci Food Agric"},{"key":"3333_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1208\/s12249-020-1621-7","volume":"21","author":"T Liu","year":"2020","unstructured":"Liu T, Yu X, Yin H. Study of top-down and bottom-up approaches by using design of experiment (DoE) to produce meloxicam nanocrystal capsules. AAPS PharmSciTech. 2020;21:79. https:\/\/doi.org\/10.1208\/s12249-020-1621-7.","journal-title":"AAPS PharmSciTech"},{"key":"3333_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","volume":"46","author":"E Baka","year":"2008","unstructured":"Baka E, Comer JEA, Tak\u00e1cs-Nov\u00e1k K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335\u201341. https:\/\/doi.org\/10.1016\/j.jpba.2007.10.030.","journal-title":"J Pharm Biomed Anal"},{"key":"3333_CR33","doi-asserted-by":"publisher","first-page":"9153","DOI":"10.1007\/s10973-025-14231-7","volume":"150","author":"S Sharma","year":"2025","unstructured":"Sharma S, Kunjir SA, Pathare PR, Deoriya J, Sahoo A, Malayandi R. Effect of solid-state characteristics and buffers on the solubility and dissolution behaviors of mesalamine. J Therm Anal Calorim. 2025;150:9153\u201369. https:\/\/doi.org\/10.1007\/s10973-025-14231-7.","journal-title":"J Therm Anal Calorim"},{"issue":"2","key":"3333_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7508\/nmrj.2016.02.006","volume":"1","author":"S Seifirad","year":"2016","unstructured":"Seifirad S, Karami H, Shahsavari S, Mirabbasi F, Dorkoosh FA. Design and characterization of mesalamine loaded nanoparticles for controlled delivery system. Nanomed Res J. 2016;1(2):97\u2013106. https:\/\/doi.org\/10.7508\/nmrj.2016.02.006.","journal-title":"Nanomed Res J"},{"key":"3333_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-024-01712-6","volume":"15","author":"S Kunjir","year":"2024","unstructured":"Kunjir S, Pathare P, Sharma S, Malayandi R, Malgave A, Natesan S. Development and validation of particle size measurement for mesalamine nanocrystals using dynamic light scattering and microscopic techniques. BioNanoSci. 2024;15: 27. https:\/\/doi.org\/10.1007\/s12668-024-01712-6.","journal-title":"BioNanoSci"},{"key":"3333_CR36","doi-asserted-by":"publisher","first-page":"28827","DOI":"10.1021\/acsomega.4c03240","volume":"9","author":"H Liaqat","year":"2024","unstructured":"Liaqat H, Badshah SF, Minhas MU, Barkat K, Khan SA, Hussain MD, et al. pH-sensitive hydrogels fabricated with hyaluronic acid as a polymer for site-specific delivery of mesalamine. ACS Omega. 2024;9:28827\u201340. https:\/\/doi.org\/10.1021\/acsomega.4c03240.","journal-title":"ACS Omega"},{"key":"3333_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087427","volume":"24","author":"NPK Le","year":"2023","unstructured":"Le NPK, Altenburger MJ, Lamy E. Development of an inflammation-triggered in vitro \u201cleaky gut\u201d model using Caco-2\/HT29-MTX-E12 combined with macrophage-like THP-1 cells or primary human-derived macrophages. Int J Mol Sci. 2023;24: 7427. https:\/\/doi.org\/10.3390\/ijms24087427.","journal-title":"Int J Mol Sci"},{"key":"3333_CR38","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1021\/acs.molpharmaceut.8b00655","volume":"15","author":"G Dagrada","year":"2018","unstructured":"Dagrada G, Rupel K, Zacchigna S, Tamborini E, Pilotti S, Cavalleri A, et al. Self-assembled nanomicelles as curcumin drug delivery vehicles: impact on solitary fibrous tumor cell protein expression and viability. Mol Pharmaceutics. 2018;15:4689\u2013701. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00655.","journal-title":"Mol Pharmaceutics"},{"key":"3333_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1021\/mp5006382","volume":"12","author":"R Safar","year":"2015","unstructured":"Safar R, Ronzani C, Diab R, Chevrier J, Bensoussan D, Grandemange S, et al. Human monocyte response to S -nitrosoglutathione-loaded nanoparticles: uptake, viability, and transcriptome. Mol Pharmaceutics. 2015;12:554\u201361. https:\/\/doi.org\/10.1021\/mp5006382.","journal-title":"Mol Pharmaceutics"},{"key":"3333_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23:37\u201345. https:\/\/doi.org\/10.1016\/j.intimp.2014.08.002.","journal-title":"Int Immunopharmacol"},{"key":"3333_CR41","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jconrel.2003.11.007","volume":"95","author":"XC Fu","year":"2004","unstructured":"Fu XC, Wang GP, Liang WQ, Chow MSS. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration. J Control Release. 2004;95:209\u201316. https:\/\/doi.org\/10.1016\/j.jconrel.2003.11.007.","journal-title":"J Control Release"},{"key":"3333_CR42","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1021\/acsanm.8b00038","volume":"1","author":"L Protesescu","year":"2018","unstructured":"Protesescu L, Yakunin S, Nazarenko O, Dirin DN, Kovalenko MV. Low-cost synthesis of highly luminescent colloidal lead halide perovskite nanocrystals by wet ball milling. ACS Appl Nano Mater. 2018;1:1300\u20138. https:\/\/doi.org\/10.1021\/acsanm.8b00038.","journal-title":"ACS Appl Nano Mater"},{"key":"3333_CR43","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1021\/mp100198q","volume":"7","author":"HM Fadda","year":"2010","unstructured":"Fadda HM, Sousa T, Carlsson AS, Abrahamsson B, Williams JG, Kumar D, et al. Drug solubility in luminal fluids from different regions of the small and large intestine of humans. Mol Pharm. 2010;7:1527\u201332. https:\/\/doi.org\/10.1021\/mp100198q.","journal-title":"Mol Pharm"},{"key":"3333_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121567","volume":"16","author":"Y Maeda","year":"2024","unstructured":"Maeda Y, Goto Y, Ohnishi F, Koga S, Kawano S, Hieda Y, et al. 5-aminosalicylic acid distribution into the intestinal membrane along the gastrointestinal tract after oral administration in rats. Pharmaceutics. 2024;16: 1567. https:\/\/doi.org\/10.3390\/pharmaceutics16121567.","journal-title":"Pharmaceutics"},{"key":"3333_CR45","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.measurement.2013.02.005","volume":"46","author":"A Canakci","year":"2013","unstructured":"Canakci A, Varol T, Ozsahin S. Analysis of the effect of a new process control agent technique on the mechanical milling process using a neural network model: measurement and modeling. Measurement. 2013;46:1818\u201327. https:\/\/doi.org\/10.1016\/j.measurement.2013.02.005.","journal-title":"Measurement"},{"key":"3333_CR46","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/ma17020435","volume":"17","author":"SB Gasha","year":"2024","unstructured":"Gasha SB, Trautmann M, Wagner G. Effect of milling time and reinforcement volume fraction on microstructure and mechanical properties of SiCp-reinforced AA2017 composite powder produced by high-energy ball milling. Materials (Basel). 2024;17:435. https:\/\/doi.org\/10.3390\/ma17020435.","journal-title":"Materials (Basel)"},{"key":"3333_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2013.07.021","volume":"455","author":"B Zuo","year":"2013","unstructured":"Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J, et al. Preparation and in vitro\/in vivo evaluation of fenofibrate nanocrystals. Int J Pharm. 2013;455:267\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.021.","journal-title":"Int J Pharm"},{"key":"3333_CR48","doi-asserted-by":"publisher","unstructured":"Da Silva JBA, Pereira FV, Druzian JI. Cassava starch\u2010based films plasticized with sucrose and inverted sugar and reinforced with cellulose nanocrystals. J Food Sci [Internet]. 2012;77. [cited 2025 Oct 27]. https:\/\/doi.org\/10.1111\/j.1750-3841.2012.02710.x.","DOI":"10.1111\/j.1750-3841.2012.02710.x"},{"key":"3333_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/nano12193421","volume":"12","author":"D Choque-Quispe","year":"2022","unstructured":"Choque-Quispe D, Choque-Quispe Y, Ligarda-Samanez CA, Peralta-Guevara DE, Solano-Reynoso AM, Ramos-Pacheco BS, et al. Effect of the addition of corn husk cellulose nanocrystals in the development of a novel edible film. Nanomaterials. 2022;12: 3421. https:\/\/doi.org\/10.3390\/nano12193421.","journal-title":"Nanomaterials"},{"key":"3333_CR50","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/j.slasd.2025.100248","volume":"35","author":"S Peddibhotla","year":"2025","unstructured":"Peddibhotla S, Boone LA, Taylor EL, McQueen BE, Boazak EM. A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies. SLAS Discov. 2025;35:100248. https:\/\/doi.org\/10.1016\/j.slasd.2025.100248.","journal-title":"SLAS Discov"},{"key":"3333_CR51","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1053\/j.gastro.2015.07.003","volume":"149","author":"BE Sands","year":"2015","unstructured":"Sands BE. Biomarkers of inflammation in inflammatory bowel disease. Gastroenterology. 2015;149:1275-1285.e2. https:\/\/doi.org\/10.1053\/j.gastro.2015.07.003.","journal-title":"Gastroenterology"},{"key":"3333_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201700629","volume":"6","author":"N Kerdsakundee","year":"2017","unstructured":"Kerdsakundee N, Li W, Martins JP, Liu Z, Zhang F, Kemell M, et al. Multifunctional nanotube\u2013mucoadhesive poly(methyl vinyl ether\u2010 co \u2010maleic acid)@hydroxypropyl methylcellulose acetate succinate composite for site\u2010specific oral drug delivery. Adv Healthc Mater. 2017;6: 1700629. https:\/\/doi.org\/10.1002\/adhm.201700629.","journal-title":"Adv Healthc Mater"},{"key":"3333_CR53","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1021\/acsanm.0c00498","volume":"3","author":"A Lu","year":"2020","unstructured":"Lu A, Petit E, Wang Y, Su F, Li S. Synthesis and self-assembly of hydroxypropyl methyl cellulose- block -poly(\u03b5-caprolactone) copolymers as nanocarriers of lipophilic drugs. ACS Appl Nano Mater. 2020;3:4367\u201375. https:\/\/doi.org\/10.1021\/acsanm.0c00498.","journal-title":"ACS Appl Nano Mater"},{"key":"3333_CR54","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1208\/s12248-015-9774-0","volume":"17","author":"Y Chen","year":"2015","unstructured":"Chen Y, Li T. Cellular uptake mechanism of paclitaxel nanocrystals determined by confocal imaging and kinetic measurement. AAPS J. 2015;17:1126\u201334. https:\/\/doi.org\/10.1208\/s12248-015-9774-0.","journal-title":"AAPS J"},{"key":"3333_CR55","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1084\/jem.20021340","volume":"196","author":"SC Eisenbarth","year":"2002","unstructured":"Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002;196:1645\u201351. https:\/\/doi.org\/10.1084\/jem.20021340.","journal-title":"J Exp Med"},{"key":"3333_CR56","doi-asserted-by":"publisher","unstructured":"Eom YW, Hong J-E, Jung PY, Yoon Y, Yoo S-H, Hong J et al. TGF-\u03b2 expressed by M2 macrophages promotes wound healing by inhibiting TSG-6 expression by mesenchymal stem cells. Yuan Z, editor. PLoS ONE. 2025;20:e0316692. https:\/\/doi.org\/10.1371\/journal.pone.0316692","DOI":"10.1371\/journal.pone.0316692"},{"key":"3333_CR57","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1039\/d3tb02312e","volume":"12","author":"X Wu","year":"2024","unstructured":"Wu X, Zhang Q, Peng L, Tian Z, Gou G, Zuo W, et al. Colon-targeted piperine-glycyrrhizic acid nanocrystals for ulcerative colitis synergetic therapy via macrophage polarization. J Mater Chem B. 2024;12:1604\u201316. https:\/\/doi.org\/10.1039\/d3tb02312e.","journal-title":"J Mater Chem B"},{"key":"3333_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113079","volume":"151","author":"S Li","year":"2022","unstructured":"Li S, Zhang F, Zhang Q. Pathological features-based targeted delivery strategies in IBD therapy: a mini review. Biomed Pharmacother. 2022;151: 113079. https:\/\/doi.org\/10.1016\/j.biopha.2022.113079.","journal-title":"Biomed Pharmacother"},{"key":"3333_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells8020193","volume":"8","author":"I Schoultz","year":"2019","unstructured":"Schoultz I, Keita \u00c5V. Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function. Cells. 2019;8: 193. https:\/\/doi.org\/10.3390\/cells8020193.","journal-title":"Cells"},{"key":"3333_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/japtr.japtr_538_23","volume":"15","author":"MNF Roslan","year":"2024","unstructured":"Roslan MNF, Naharudin I, Musa N, Anuar NK. Bioadhesive polymer in antifungal drug delivery for therapeutic treatment of candidiasis. J Adv Pharm Technol Res. 2024;15:139\u201343. https:\/\/doi.org\/10.4103\/japtr.japtr_538_23.","journal-title":"J Adv Pharm Technol Res"},{"key":"3333_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052796","volume":"25","author":"W Murphy","year":"2024","unstructured":"Murphy W, Liu S, Javadiyan S, Vyskocil E, Feizi S, Callejas C, et al. An in vitro study evaluating the safety of mesalazine on human nasoepithelial cells. Int J Mol Sci. 2024;25: 2796. https:\/\/doi.org\/10.3390\/ijms25052796.","journal-title":"Int J Mol Sci"},{"key":"3333_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.5607\/en.2012.21.4.151","volume":"21","author":"K-Y Ryu","year":"2012","unstructured":"Ryu K-Y, Cho G-S, Piao HZ, Kim W-K. Role of TGF-\u03b2 in survival of phagocytizing microglia: autocrine suppression of TNF-\u03b1 production and oxidative stress. Exp Neurobiol. 2012;21:151\u20137. https:\/\/doi.org\/10.5607\/en.2012.21.4.151.","journal-title":"Exp Neurobiol"},{"issue":"Suppl 5","key":"3333_CR63","doi-asserted-by":"publisher","first-page":"v5","DOI":"10.1093\/rheumatology\/ken275","volume":"47","author":"R Sgonc","year":"2008","unstructured":"Sgonc R, Wick G. Pro- and anti-fibrotic effects of TGF-beta in scleroderma. Rheumatology (Oxford). 2008;47(Suppl 5):v5-7. https:\/\/doi.org\/10.1093\/rheumatology\/ken275.","journal-title":"Rheumatology (Oxford)"},{"key":"3333_CR64","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1111\/bcp.15476","volume":"88","author":"F Liu","year":"2022","unstructured":"Liu F, Aulin LBS, Guo T, Krekels EHJ, Moerland M, Van Der Graaf PH, et al. Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equations. Br J Clin Pharmacol. 2022;88:5420\u20137. https:\/\/doi.org\/10.1111\/bcp.15476.","journal-title":"Br J Clin Pharmacol"},{"key":"3333_CR65","doi-asserted-by":"publisher","first-page":"29391","DOI":"10.1074\/jbc.M109.005272","volume":"284","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Chen L-Y, Papadimos TJ, Huang S, Zuraw BL, Pan ZK. Lipopolysaccharide-driven Th2 cytokine production in macrophages is regulated by both MyD88 and TRAM. J Biol Chem. 2009;284:29391\u20138. https:\/\/doi.org\/10.1074\/jbc.M109.005272.","journal-title":"J Biol Chem"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03333-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03333-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:46:51Z","timestamp":1772228811000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03333-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["3333"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03333-6","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Yes). The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: (No).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"91"}}